We converse with Dr Faz Chowdhury, CEO of Nemaura Medical relating to the ground-breaking expertise of non-invasive glucose sensors and extra
Digital well being, wearables, self-management and preventative medication are the way forward for medication, and Nemaura Medical consider that they’re nicely poised to make vital contributions on this area. Dr Faz Chowdhury discusses right here with Open Entry Authorities the methods by which Nemaura are innovatively contributing to stopping and reversing Type 2 diabetes, in addition to increasing their providing to metabolic well being.
Please inform us a bit extra about what you do, and your work at UK-based medical expertise firm Nemaura Medical?
Nemaura Medical is now 11 years outdated, and we spent the primary 10 years creating what’s now the world’s first non-invasive glucose sensor technology platform. Mainly, we developed a sensor that may be caught to the arm to measure glucose from the pores and skin and supply the profile of the glucose fluctuations over time, over the course of the day.
The sensor is just not implanted or pierced deep into the pores and skin just like the competing marketed units. The expertise is a CE marked class 2B medical gadget and we’re engaged on different sensors that can be utilized utilizing the identical gadget equivalent to lactate and alcohol sensors.
Why is it necessary to empower folks to take cost of their very own well being and wellbeing, notably these with Diabetes?
There are substantial problems that come up from diabetes. For starters, virtually 15% of healthcare budgets world wide are devoted to coping with diabetes and its problems. Mixed with poor high quality of life, this imposes an enormous burden on each the healthcare suppliers in addition to the affected person.
The one option to actually management the long-term problems is to reign within the blood glucose fluctuations that happen every day by way of a complete host of interventions together with medication, weight loss program and train. To measure the fluctuations and the extent to which an individual has been capable of management and reign in these blood glucose fluctuations they require a steady sensor, and this empowers the person to remain in management and monitor and usually monitor their progress.
In your earlier article for Open Entry Authorities, you talk about Nemaura’s product sugarBEAT, the world’s first non-invasive CGM (Steady Glucose Monitor). Since its launch, how has it been serving to folks not simply within the UK however all around the world?
We at the moment are increasing our providing to metabolic well being, which in a nutshell is about measuring insulin resistance. A person can put on the gadget for only a few hours on one or two days every month and they’re going to get their metabolic well being rating (which we hyperlink again to insulin resistance).
That is ground-breaking in some ways in that insulin resistance is just not merely a precursor to diabetes however can result in continual ailments equivalent to dementia in addition to heart problems. The good factor is this can be a preventative device and relevant to virtually one in two folks desirous to take a pre-emptive proactive strategy to take care of their well being, lengthy earlier than the precise illness manifests itself.
How can CGM assist in monitoring illness development and bettering outcomes in sufferers contaminated with COVID-19?
There have been a number of journal articles which have linked COVID-19 to elevated blood glucose levels. It may very well be an excellent device to measure this, since sufferers would solely want to make use of a single sensor and solely make the measurement just a few instances within the month to verify the regression of the signs of COVID-19.
What do you hope for the way forward for sort 2 diabetes care, and the way will Nemaura Medical proceed work in direction of this?
Our major objective is to assist stem the tide of Sort 2 diabetes by combining small incremental manageable modifications in way of life and weight loss program with sugarBEAT as a monitoring device to maintain customers knowledgeable of their progress. Secondly, we goal to stop as many individuals as attainable from changing into Sort 2 within the first place by pre-emptively monitoring and monitoring their insulin resistance ranges.
Please observe: It is a business profile